EXPERTISE IN ALL ASPECTS OF HEALTH ECONOMICS AND OUTCOMES RESEARCH
Payers are increasingly seeking clinical and economic evidence that applies to their beneficiaries. Clinical trial data are often limited to selected populations, and are unrepresentative of actual use. Pragmatic studies in real-world settings provide data that truly reflect target populations in current clinical practice.
We have developed expertise in conducting pragmatic trials in both hospital and ambulatory settings. These studies enable gathering clinical and economic data for use in economic evaluations of real-world drug use. Economic evaluations based on pragmatic study results are better adapted to payers’ needs. More specifically, real-world studies can be used:
- To confirm, in real-life settings and for targeted populations, the clinical benefits observed in clinical trials;
- To estimate the treatment impact on various HEOR measures;
- Quality of life;
- Productivity loss;
- To assess the economic impact of treatments in real-life settings and to collect relevant analysis data from a societal perspective.